Additionally, PTEN-deficient tumours show increased expression of immune evasion markers, including programmed death-ligand 1 (PD-L1) and indoleamine 2,3-dioxygenase 1 (IDO1), which damage the cytotoxic activity of immune cells and facilitate immune escape (18). Here, IDO1 is linked to neoplasm.